M&A - Envoy Medical, Inc.

Form Type: 10-K

Filing Date: 2025-03-31

Corporate Action: Merger

Type: Update

Accession Number: 000101376225004299

Filing Summary: Envoy Medical, Inc., formerly known as Anzu Special Acquisition Corp I, completed its Business Combination with Legacy Envoy on September 2023. This merger involved the conversion of Legacy Envoy's Preferred Stock and Common Stock into shares of Envoy Medical's Class A Common Stock and the cancellation of options and warrants related to Legacy Envoy. The total shares of Class A Common Stock outstanding increased to 21,326,619 as of March 24, 2025. The Company plans to focus on the commercialization of its product, the fully implanted Acclaim CI, which utilizes established sensor technology to revolutionize the cochlear implant market. The Business Combination allows Envoy Medical to leverage operational synergies and deepen its engagement in the medical technology sector.